Canopy Growth/$CGC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Canopy Growth
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
Ticker
$CGC
Sector
Primary listing
Employees
960
Headquarters
Smiths Falls, Canada
Website
Canopy Growth Metrics
BasicAdvanced
$456M
-
-$2.76
2.42
-
Price and volume
Market cap
$456M
Beta
2.42
52-week high
$5.25
52-week low
$0.77
Average daily volume
27M
Financial strength
Current ratio
3.075
Quick ratio
1.965
Long term debt to equity
63.169
Total debt to equity
67.038
Interest coverage (TTM)
-0.96%
Profitability
EBITDA (TTM)
-13.953
Gross margin (TTM)
27.83%
Net profit margin (TTM)
-186.42%
Operating margin (TTM)
-22.17%
Effective tax rate (TTM)
-0.24%
Revenue per employee (TTM)
$210,930
Management effectiveness
Return on assets (TTM)
-3.48%
Return on equity (TTM)
-101.08%
Valuation
Price to revenue (TTM)
0.978
Price to book
0.84
Price to tangible book (TTM)
1.15
Price to free cash flow (TTM)
-2.019
Free cash flow yield (TTM)
-49.54%
Free cash flow per share (TTM)
-0.718
Growth
Revenue change (TTM)
-4.24%
Earnings per share change (TTM)
-58.82%
3-year revenue growth (CAGR)
-16.15%
10-year revenue growth (CAGR)
55.07%
3-year earnings per share growth (CAGR)
-62.24%
10-year earnings per share growth (CAGR)
9.78%
What the Analysts think about Canopy Growth
Analyst ratings (Buy, Hold, Sell) for Canopy Growth stock.
Bulls say / Bears say
Net revenue from medical cannabis in Canada rose 13% in Q4 FY2025, leading to a 4% year-over-year increase in Canadian cannabis revenue (GuruFocus).
Total debt was reduced by C$293 million (49%) during FY2025, substantially improving the balance sheet and cutting annual interest expenses (GuruFocus).
New cost-cutting efforts launched in Q4 FY2025 are projected to generate at least C$20 million in annualized savings over the next 12–18 months, further boosting margins (GuruFocus).
International markets cannabis net revenue fell 35% to C$7.5 million in Q4 FY2025 from C$11.6 million, showing weaker demand in major European and Australian markets (Canopy Growth press release).
Net revenue from the Storz & Bickel segment dropped 23% year-over-year in Q4 FY2025 to C$17.1 million, highlighting softness in the vaporizer category (Canopy Growth press release).
Free cash flow showed an outflow of C$36 million in Q4 FY2025, a 60% greater outflow than the previous year, pointing to persistent cash burn and liquidity concerns (GuruFocus).
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Canopy Growth Financial Performance
Revenues and expenses
Canopy Growth Earnings Performance
Company profitability
Canopy Growth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Canopy Growth stock?
Canopy Growth (CGC) has a market cap of $456M as of September 18, 2025.
What is the P/E ratio for Canopy Growth stock?
The price to earnings (P/E) ratio for Canopy Growth (CGC) stock is 0 as of September 18, 2025.
Does Canopy Growth stock pay dividends?
No, Canopy Growth (CGC) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Canopy Growth dividend payment date?
Canopy Growth (CGC) stock does not pay dividends to its shareholders.
What is the beta indicator for Canopy Growth?
Canopy Growth (CGC) has a beta rating of 2.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.